The NIPT market's growth opportunities lie in expanding its clinical applications, leveraging advanced sequencing technologies, and increasing adoption for low-risk pregnancies. Rising maternal age, ...
A new non-invasive test that examines fetal DNA can pick up genetic abnormalities such as Down's syndrome and, unlike more intrusive tests that may raise the risk of miscarriage, it poses no threat to ...
Pregnant women can have prenatal testing performed during their pregnancies to determine whether or not their baby could have certain disorders. Two types of tests are chorionic villus sampling (CVS) ...
Non-invasive prenatal tests (NIPTs) are increasingly an integral part of screening during pregnancies across the world. Research from Amsterdam UMC shows that a pregnant woman's genetic background ...
In December 2022, the American College of Medical Genetics and Genomics made a recommendation that all expectant mothers should be offered non-invasive prenatal testing (NIPT) instead of traditional ...
A team of investigators from Massachusetts General Hospital (MGH), Brigham and Women's Hospital (BWH), and the Broad Institute of MIT and Harvard have developed a non-invasive genetic test that can ...
MANCHESTER, England & BOGOTÁ, Colombia--(BUSINESS WIRE)--Yourgene Health (part of the Novacyt group of companies), a leading international molecular diagnostics ...
Yourgene Health (part of the Novacyt group of companies), a leading international molecular diagnostics group, today announced the launch of IONA ® Care+, a fully comprehensive non-invasive prenatal ...
Researchers have developed a non-invasive genetic test that can screen the blood of pregnant individuals to survey all genes from the fetal genome. A team of investigators from Massachusetts General ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results